Matches in Wikidata for { <http://www.wikidata.org/entity/Q100788955> ?p ?o ?g. }
Showing items 1 to 40 of
40
with 100 items per page.
- Q100788955 description "clinical trial" @default.
- Q100788955 description "ensayo clínico" @default.
- Q100788955 description "ensayu clínicu" @default.
- Q100788955 description "klinisch onderzoek" @default.
- Q100788955 description "клінічне випробування" @default.
- Q100788955 description "կլինիկական փորձարկում" @default.
- Q100788955 description "临床试验" @default.
- Q100788955 name "A Study of MRG002 in Patients With HER2-Positive Advanced Solid Tumors and Locally Advanced or Metastatic Gastric/Gastroesophageal Junction (GEJ) Cancer" @default.
- Q100788955 name "A Study of MRG002 in Patients With HER2-Positive Advanced Solid Tumors and Locally Advanced or Metastatic Gastric/Gastroesophageal Junction (GEJ) Cancer" @default.
- Q100788955 type Item @default.
- Q100788955 label "A Study of MRG002 in Patients With HER2-Positive Advanced Solid Tumors and Locally Advanced or Metastatic Gastric/Gastroesophageal Junction (GEJ) Cancer" @default.
- Q100788955 label "A Study of MRG002 in Patients With HER2-Positive Advanced Solid Tumors and Locally Advanced or Metastatic Gastric/Gastroesophageal Junction (GEJ) Cancer" @default.
- Q100788955 prefLabel "A Study of MRG002 in Patients With HER2-Positive Advanced Solid Tumors and Locally Advanced or Metastatic Gastric/Gastroesophageal Junction (GEJ) Cancer" @default.
- Q100788955 prefLabel "A Study of MRG002 in Patients With HER2-Positive Advanced Solid Tumors and Locally Advanced or Metastatic Gastric/Gastroesophageal Junction (GEJ) Cancer" @default.
- Q100788955 P1132 Q100788955-9078058B-5F1F-4C44-9810-C9B74AC5753B @default.
- Q100788955 P1476 Q100788955-0878043A-8279-416D-8813-12D3A802BE07 @default.
- Q100788955 P17 Q100788955-0C70D7FF-C25C-42EF-AAE5-338A3BB48D8D @default.
- Q100788955 P2899 Q100788955-D22F56DF-FE25-46C4-A7BE-87A46B1068FF @default.
- Q100788955 P3098 Q100788955-D51BB2E8-3604-49EB-BB74-46178CF78A59 @default.
- Q100788955 P31 Q100788955-CADB1E59-2434-4F8E-B34D-338DC9B18E84 @default.
- Q100788955 P580 Q100788955-FCD8956F-9755-4EAD-AE9B-E630FCE3A23E @default.
- Q100788955 P582 Q100788955-605BFC90-0528-4957-8367-48D68098ED19 @default.
- Q100788955 P6099 Q100788955-3FF65B2D-81FF-438B-957C-DCDAB2E4F868 @default.
- Q100788955 P6099 Q100788955-C04D8A7F-B385-4A43-AC93-72ED5B6A097B @default.
- Q100788955 P6153 Q100788955-544E3D97-0E92-4126-A0B0-C91635D0DF42 @default.
- Q100788955 P8005 Q100788955-209EDA0B-0A57-47A0-9E0E-9DBE4C8E5EEF @default.
- Q100788955 P8363 Q100788955-08C54929-B53F-4049-B634-0AF353BB7FF4 @default.
- Q100788955 P1132 "+152" @default.
- Q100788955 P1476 "An Open-Label, Multi-center Phase I/II Dose Escalation and Expansion Study to Assess the Safety, Efficacy and Pharmacokinetics of MRG002 in Patients With HER2-Positive Advanced Solid Tumors and Locally Advanced or Metastatic Gastric/Gastroesophageal Junction (GEJ) Cancer" @default.
- Q100788955 P17 Q30 @default.
- Q100788955 P2899 "+18" @default.
- Q100788955 P3098 "NCT04492488" @default.
- Q100788955 P31 Q30612 @default.
- Q100788955 P580 "2020-08-24T00:00:00Z" @default.
- Q100788955 P582 "2022-12-01T00:00:00Z" @default.
- Q100788955 P6099 Q42824440 @default.
- Q100788955 P6099 Q5452194 @default.
- Q100788955 P6153 Q30269842 @default.
- Q100788955 P8005 Q76649708 @default.
- Q100788955 P8363 Q78089383 @default.